Changes in cancer diagnoses and stage distribution during the first year of the COVID-19 pandemic in the USA: a cross-sectional nationwide assessmentXuesong Han, Ahmedin Jemal, Changchuan Jiang et al.|The Lancet Oncology|2023Cited by 67
Assessment of Changes in Cancer Treatment During the First Year of the COVID-19 Pandemic in the USLetícia Nogueira, K. Robin Yabroff, Ahmedin Jemal et al.|JAMA Oncology|2023Cited by 15
Changes in time-to-treatment initiation for breast, non-small cell lung, colon, or rectal cancers throughout the COVID-19 pandemic in the United StatesQinjin Fan, Letícia Nogueira, K. Robin Yabroff et al.|JNCI Journal of the National Cancer Institute|2025Cited by 4
Changes in time to treatment initiation for patients diagnosed with breast, lung, colon, or rectal cancer during the 2020 COVID-19 pandemic in the US.Qinjin Fan, Letícia Nogueira, K. Robin Yabroff et al.|Journal of Clinical Oncology|2023Cited by 1
Implications of the initial <i>Braidwood v. Becerra</i> ruling for colorectal cancer outcomes: a modeling studyRosita van den Puttelaar, Iris Lansdorp‐Vogelaar, K. Robin Yabroff et al.|JNCI Journal of the National Cancer Institute|2024Cited by 1